Funding Requirements
Funding Requirements and Uses of Funds
The company seeks funding for Asset Purchase, R&D Expense, Clinical Trial Expense, and General Administrative Expense to complete the clinical trial and receive FDA clearance over a period of the next 24 months.
Investment Summary
​​​Over $50 million has already been invested in the underlying Lumivascular platform, establishing a solid technological and regulatory foundation.
By investing in Lumivascular, you are supporting a game-changing technology poised to redefine the treatment of coronary CTOs. With a compelling market opportunity, differentiated technology that addresses unmet clinical needs, and a proven team, we offer investors the potential for significant returns while making a meaningful impact on patient care. For more information or to schedule a detailed presentation, please contact us at info@lumivascular.us